YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering

NCT01837823 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Coronary Artery Disease
Coronary Artery Disease

Interventions

DRUG: rosuvastatin

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]
[object Object]